Literature DB >> 2512150

Serovars of Chlamydia trachomatis causing postabortion salpingitis.

K Persson1, S Osser.   

Abstract

In a previously reported investigation, 69 women with genital chlamydial infection following legal abortion were studied prospectively. Ten cases of postabortion salpingitis and 16 cases of endometritis were identified. To ascertain whether some serovars of Chlamydia trachomatis are particularly likely to initiate an infection in the fallopian tubes and cause salpingitis, the chlamydial isolates from the patients with salpingitis and those isolates from cases free of infectious complications were serotyped using a panel of monoclonal antibodies. Six of the seven different serovars demonstrated in the symptom-free group were identified in salpingitis cases. The strains associated with salpingitis seemed to reflect the overall distribution of chlamydial serovars in the entire study group. The predominant serovars were E, F and H. A protective effect associated with chlamydial serum antibodies had previously been observed in salpingitis cases. Therefore, the antibody titres subdivided according to serovar were compared. No difference in the antibody response induced by the different serovars could be verified statistically, but the B-complex strains were associated with a higher antibody titre than the C-complex strains or the intermediate strains F and G.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2512150     DOI: 10.1007/bf02185848

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  9 in total

1.  Serovar distribution of urogenital Chlamydia trachomatis strains in The Netherlands.

Authors:  J H Wagenvoort; R J Suchland; W E Stamm
Journal:  Genitourin Med       Date:  1988-06

2.  Chlamydia trachomatis immunotypes in Finland.

Authors:  P Saikku; S P Wang
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1987-04

3.  Chlamydial infection. Results of micro-immunofluorescence tests for the detection of type-specific antibody in certain chlamydial infections.

Authors:  R S Dwyer; J D Treharne; B R Jones; J Herring
Journal:  Br J Vener Dis       Date:  1972-12

4.  Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test.

Authors:  S P Wang; J T Grayston
Journal:  Am J Ophthalmol       Date:  1970-09       Impact factor: 5.258

5.  Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington.

Authors:  C C Kuo; S P Wang; K K Holmes; J T Grayston
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

6.  Immunotyping of Chlamydia trachomatis with monoclonal antibodies.

Authors:  S P Wang; C C Kuo; R C Barnes; R S Stephens; J T Grayston
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

7.  Comparison of Chlamydia trachomatis serovars causing rectal and cervical infections.

Authors:  R C Barnes; A M Rompalo; W E Stamm
Journal:  J Infect Dis       Date:  1987-12       Impact factor: 5.226

8.  Postabortal Chlamydia trachomatis salpingitis: correlating risk with antigen-specific serological responses and with neutralization.

Authors:  R C Brunham; R Peeling; I Maclean; J McDowell; K Persson; S Osser
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

9.  Postabortal pelvic infection associated with Chlamydia trachomatis and the influence of humoral immunity.

Authors:  S Osser; K Persson
Journal:  Am J Obstet Gynecol       Date:  1984-11-15       Impact factor: 8.661

  9 in total
  10 in total

1.  Typing of Chlamydia trachomatis by restriction endonuclease analysis of the amplified major outer membrane protein gene.

Authors:  P Rodriguez; A Vekris; B de Barbeyrac; B Dutilh; J Bonnet; C Bebear
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

2.  Identification of individual genotypes of Chlamydia trachomatis from experimentally mixed serovars and mixed infections among trachoma patients.

Authors:  D Dean; R S Stephens
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

3.  Use of a reverse dot blot procedure to identify the presence of multiple serovars in Chlamydia trachomatis urogenital infection.

Authors:  D R Stothard
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

4.  Differences in clinical manifestations of genital chlamydial infections related to serovars.

Authors:  M J van de Laar; Y T van Duynhoven; J S Fennema; J M Ossewaarde; A J van den Brule; G J van Doornum; R A Coutinho; J A van den Hoek
Journal:  Genitourin Med       Date:  1996-08

Review 5.  Controversies in family planning: postabortal pelvic inflammatory disease.

Authors:  Jennefer A Russo; Sharon Achilles; Teresa DePineres; Laura Gil
Journal:  Contraception       Date:  2012-05-29       Impact factor: 3.375

6.  Chlamydia trachomatis serovar differentiation by direct sequence analysis of the variable segment 4 region of the major outer membrane protein gene.

Authors:  E Poole; I Lamont
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

7.  Patients with Chlamydia-associated arthritis have ocular (trachoma), not genital, serovars of C. trachomatis in synovial tissue.

Authors:  Hervé C Gerard; Jessica A Stanich; Judith A Whittum-Hudson; H Ralph Schumacher; John D Carter; Alan P Hudson
Journal:  Microb Pathog       Date:  2009-11-18       Impact factor: 3.738

8.  The major outer membrane protein of a single Chlamydia trachomatis serovar can possess more than one serovar-specific epitope.

Authors:  B E Batteiger
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

9.  Evaluation of molecular typing for epidemiological study of Chlamydia trachomatis genital infections.

Authors:  P Rodriguez; B de Barbeyrac; K Persson; B Dutilh; C Bebear
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

10.  Lack of evidence of a relationship between genital symptoms, cervicitis and salpingitis and different serovars of Chlamydia trachomatis.

Authors:  K Persson; S Osser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-03       Impact factor: 3.267

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.